Skip to content

David Michael Reich, MD

NPI 1568541936ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Jamaica, NY

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Jamaica, New York, licensed in NY, with an NPI issued in November 2006. Part D covered 4,005 prescriptions written in 2024, 42% of them generic. Novo Nordisk Inc was the largest of 8 companies reporting payments in 2025, $281.14 in all, mostly food and beverage.

Overview

NPI1568541936
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedNov 4, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (NY)

Part D prescriptions in 2024

Prescriptions (claims)4,005 · 8,204 30-day fills
Patients261
Total drug cost$1,739,462
Generic share42% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$281.14 · 13 payments from 8 companies
  • 2024$469.70 · 25 payments from 10 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$84.174
Amgen Inc.$48.552
Abbott Laboratories$30.502
Corcept Therapeutics$26.241
Lilly USA, LLC$25.041

What the 2025 payments were for

  • Food and Beverage$281.14 · 13 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Jamaica

All endocrinologists in New York